Log in to your Inderes Free account to see all free content on this page.

Circio Holding

Less than 1K followers

CRNA

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview

Ownership

Investor consensus

Circio Holding is a pharmaceutical company. The company's specialist expertise is found in targeted immunotherapy used in the treatment of cancer patients. The company's operations consist of research and development and the medicines are sold under separate brands. Several partnerships in the market have been entered into to strengthen cooperation in the development of new immunotherapy. The company was founded in 2010 and is headquartered in Lysaker.

Market cap

-

Turnover

-

Revenue

EBIT %

P/E

Dividend yield-%

All

Press releases

ShowingAll content types

Regulatory press release12/3/2025, 2:23 PM

Corr*: Atlas Holdings for CIRCIO

Regulatory press release12/3/2025, 11:36 AM

CRNA: Atlas Holdings for CIRCIO

Regulatory press release11/25/2025, 2:22 PM

CRNA: Atlas Holdings for CIRCIO

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release11/24/2025, 6:00 AM

Circio presents data that further strengthens and broadens its circVec circular RNA expression platform

Regulatory press release11/20/2025, 4:28 PM

Shareholding disclosure - Nordnet AB (publ)

Regulatory press release11/20/2025, 1:38 PM

Shareholding disclosure - Nordnet AB (publ)

Regulatory press release11/19/2025, 3:53 PM

Shareholding disclosure - Nordnet AB (publ)

Regulatory press release11/19/2025, 3:32 PM

CRNA: Atlas Holdings for CIRCIO

Regulatory press release11/19/2025, 3:27 PM

Shareholding disclosure - Nordnet AB (publ)

Regulatory press release11/19/2025, 12:04 PM

Shareholding Disclosure - Nordnet

Regulatory press release11/18/2025, 4:11 PM

Shareholding disclosure - Nordnet AB (publ)

Press release11/17/2025, 1:00 PM

Circio issues invitation to R&D and corporate update webcast on 24 November 2025

Regulatory press release11/3/2025, 7:13 AM

Corr: Atlas Holdings for CIRCIO

Regulatory press release10/30/2025, 10:02 AM

Corr: Atlas Holdings for CIRCIO

Regulatory press release10/30/2025, 7:04 AM

CRNA: Atlas Holdings for CIRCIO

Regulatory press release10/19/2025, 7:45 PM

Circio Holding ASA – Bond conversion and additional trading restrictions

Regulatory press release10/17/2025, 2:39 PM

Circio Holding ASA: Requested Conversion of Convertible Bonds

Regulatory press release10/15/2025, 9:14 AM

Circio Holding ASA: Requested Conversion of Convertible Bonds

Regulatory press release10/8/2025, 5:00 AM

Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025

Regulatory press release10/6/2025, 10:07 AM

Circio Holding ASA: Requested Conversion of Convertible Bonds

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.